This article is from the source 'bbc' and was first published or seen on . The next check for changes will be

You can find the current article at its original source at https://www.bbc.co.uk/news/business-49342592

The article has changed 4 times. There is an RSS feed of changes available.

Version 0 Version 1
Drugs firm to pay £8m after competition probe Drugs firm to pay NHS £8m after competition probe
(32 minutes later)
Drugs firm Aspen is to pay £8m to the NHS after an investigation into the supply of a life-saving drug to thousands of patients.Drugs firm Aspen is to pay £8m to the NHS after an investigation into the supply of a life-saving drug to thousands of patients.
The Competition and Markets Authority (CMA) said the firm offered to make the payment following an investigation.The Competition and Markets Authority (CMA) said the firm offered to make the payment following an investigation.
The CMA said it suspects competition law was broken after Aspen paid two rivals to stay out of the market.The CMA said it suspects competition law was broken after Aspen paid two rivals to stay out of the market.
This left Aspen as the only UK supplier of fludrocortisone, it added. This left Aspen as the only UK supplier of fludrocortisone and able to set prices without competition, it added.
Andrea Coscelli, the CMA's chief executive, said it was "unacceptable for the NHS - and the taxpayers who fund it - to have to pay millions of pounds more than they should for this life-saving drug".Andrea Coscelli, the CMA's chief executive, said it was "unacceptable for the NHS - and the taxpayers who fund it - to have to pay millions of pounds more than they should for this life-saving drug".
The prescription-only fludrocortisone is mainly used to treat Addison's Disease, a rare deficiency of the adrenal glands.The prescription-only fludrocortisone is mainly used to treat Addison's Disease, a rare deficiency of the adrenal glands.
This is the first time a CMA investigation will secure a payment such as this for the NHS.This is the first time a CMA investigation will secure a payment such as this for the NHS.
In addition, Aspen will ensure that there are at least two fludrocortisone suppliers in the UK.